Variable group Baseline (index admission) variablea Trial population (n=2,637)
Sociodemographics Age, median, years (IQR) 81 (74–87)
Sex, female 1,355 (51%)
Home care 679 (26%)
Residential home 322 (12%)
Unplanned visits within 12 months prior to admission ED visits (1 or more) 895 (34%)
Hospital admissions (1 or more) 1,015 (39%)
Medical history
Diagnosis in medical history:b Hypertension
Diabetes mellitus
Atrial fibrillation and flutter
Heart failure
COPD
Dementia
Peptic ulcer disease
Liver disease
1,826 (69%) 747 (28%) 725 (28%) 721 (27%) 362 (14%) 244 (9.3%) 37 (1.4%) 16 (0.6%)
Charlson Comorbidity Index score, median (IQR) 1 (0–3)
Medication use Automated drug dispensing in home setting 678 (26%)
Number of medications upon admission: 0–4
5–9
10+
500 (19%) 976 (37%) 1,161 (44%)
eGFR upon admission (mL/min/1.73 m2)c
< 15
15–29
30–59
60–89
≥ 90
112 (4.2%) 365 (14%) 1,111 (42%) 963 (37%) 77 (2.9%)
Length of hospital stay, median, days (IQR) Length of hospital stay, median, days (IQR) 8 (5–14)
Discharge diagnosis
Discharge diagnosis at index admission:b Diseases in the cerebrovascular system
Respiratory tract infections
Heart failure
Urinary tract infections
Other infections and parasite diseases
Injuries, intoxications and certain other complications of external factors
Chronic diseases of the lower respiratory tract
Atrial fibrillation and flutter
Diabetes mellitus
Ischaemic heart diseases
385 (15%) 257 (9.7%) 213 (8.1%) 149 (5.7%) 138 (5.2%) 124 (4.7%) 85 (3.2%) 72 (2.7%) 67 (2.5%) 53 (2.0%)